Jim Simons Galapagos Nv Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Galapagos Nv stock. As of the latest transaction made, Renaissance Technologies LLC holds 291,679 shares of GLPG stock, worth $7.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

291,679

Previous 270,800 7.71%

Holding current value

$7.99 Million

Previous $6.71 Million 25.14%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$24.2 - $30.67 $505,271 - $640,358	20,879 Added 7.71%	291,679 $8.4 Million
Q2 2024 Aug 09, 2024	BUY	$24.78 - $32.48 $106,554 - $139,664	4,300 Added 1.61%	270,800 $6.71 Million
Q1 2024 May 13, 2024	BUY	$32.2 - $42.44 $106,260 - $140,052	3,300 Added 1.25%	266,500 $8.58 Million
Q4 2023 Feb 13, 2024	SELL	$31.87 - $40.71 $592,782 - $757,206	-18,600 Reduced 6.6%	263,200 $10.7 Million
Q3 2023 Nov 14, 2023	SELL	$34.17 - $42.98 $891,837 - $1.12 Million	-26,100 Reduced 8.48%	281,800 $9.74 Million
Q2 2023 Aug 11, 2023	SELL	$37.4 - $44.52 $1.89 Million - $2.25 Million	-50,500 Reduced 14.09%	307,900 $12.5 Million
Q1 2023 May 12, 2023	BUY	$36.5 - $48.0 $803,730 - $1.06 Million	22,020 Added 6.55%	358,400 $13.8 Million
Q4 2022 Feb 13, 2023	BUY	$37.44 - $46.51 $1.41 Million - $1.76 Million	37,780 Added 12.65%	336,380 $14.9 Million
Q3 2022 Nov 14, 2022	BUY	$42.27 - $57.6 $2.13 Million - $2.9 Million	50,300 Added 20.26%	298,600 $12.7 Million
Q2 2022 Aug 12, 2022	BUY	$52.3 - $71.59 $8.57 Million - $11.7 Million	163,800 Added 193.85%	248,300 $13.9 Million
Q1 2022 May 13, 2022	BUY	$51.32 - $68.5 $1.43 Million - $1.91 Million	27,900 Added 49.29%	84,500 $5.24 Million
Q4 2021 Feb 11, 2022	BUY	$47.03 - $57.12 $268,071 - $325,584	5,700 Added 11.2%	56,600 $3.12 Million
Q3 2021 Nov 12, 2021	BUY	$52.17 - $70.2 $2.12 Million - $2.86 Million	40,700 Added 399.02%	50,900 $2.68 Million
Q2 2021 Aug 13, 2021	SELL	$68.86 - $83.34 $34,430 - $41,670	-500 Reduced 4.67%	10,200 $703,000
Q1 2021 May 13, 2021	SELL	$76.15 - $111.94 $4.89 Million - $7.19 Million	-64,210 Reduced 85.72%	10,700 $825,000
Q4 2020 Feb 10, 2021	SELL	$96.85 - $148.25 $10.2 Million - $15.6 Million	-105,090 Reduced 58.38%	74,910 $7.42 Million
Q3 2020 Nov 13, 2020	SELL	$122.47 - $213.56 $9.94 Million - $17.3 Million	-81,200 Reduced 31.09%	180,000 $25.5 Million
Q2 2020 Aug 13, 2020	BUY	$185.52 - $231.25 $4.83 Million - $6.01 Million	26,008 Added 11.06%	261,200 $51.5 Million
Q1 2020 May 14, 2020	BUY	$143.0 - $274.03 $33.4 Million - $64.1 Million	233,792 Added 16699.43%	235,192 $46.1 Million
Q4 2019 Feb 13, 2020	BUY	$146.12 - $215.82 $204,568 - $302,148	1,400 New	1,400 $290,000
Q3 2019 Nov 13, 2019	SELL	$130.44 - $187.64 $3.98 Million - $5.72 Million	-30,500 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$111.45 - $128.93 $2.52 Million - $2.91 Million	-22,600 Reduced 42.56%	30,500 $3.93 Million
Q1 2019 May 14, 2019	SELL	$89.61 - $117.78 $770,646 - $1.01 Million	-8,600 Reduced 13.94%	53,100 $6.25 Million
Q4 2018 Feb 13, 2019	BUY	$87.81 - $110.65 $5.42 Million - $6.83 Million	61,700 New	61,700 $5.66 Million

Others Institutions Holding GLPG

# of Institutions

Shares Held

12.3M

Call Options Held

69.1K

Put Options Held

42.7K

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.8B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account